Table 2.
Diagnosis | Control patients without delirium in first week (%) (N = 868) | Number of patients with incident delirium (%) (N = 126) | P-value (Pearson) | Odds ratios | 95 % confidence intervals |
---|---|---|---|---|---|
Pneumonia | 65 (7.49 %) | 10 (7.94 %) | 0.86 | 1.07 | 0.53 to 2.13 |
Congestive heart failure | 64 (7.37 %) | 12 (9.52 %) | 0.40 | 1.32 | 0.69 to 2.53 |
Chronic obstructive pulmonary disease exacerbation | 35 (4.03 %) | 4 (3.17 %) | 0.64 | 0.78 | 0.27 to 2.23 |
Gastrointestinal bleed | 80 (9.22 %) | 6 (4.76 %) | 0.097 | 0.49 | 0.21 to 1.15 |
Other gastrointestinal disease | 56 (6.45 %) | 6 (4.76 %) | 0.46 | 0.73 | 0.31 to 1.72 |
Urinary tract infection | 37 (4.26 %) | 7 (5.56 %) | 0.51 | 1.32 | 0.58 to 3.03 |
Cancer | 46 (5.30 %) | 8 (6.35 %) | 0.63 | 1.21 | 0.56 to 2.63 |
Falls/Functional decline | 69 (7.95 %) | 16 (12.70 %) | 0.08 | 1.68 | 0.94 to 3.01 |
TIA/Ischemic Stroke/Intracerebral Hemorrhage | 71 (8.18 %) | 4 (3.17 %) | 0.05 | 0.37 | 0.13 to 1.03 |
Endocrine/Electrolyte/Hematologic abnormality | 61 (7.03 %) | 11 (8.73 %) | 0.49 | 1.27 | 0.65 to 2.48 |
Other cardiopulmonary disease | 59 (6.80 %) | 11 (8.73 %) | 0.43 | 1.31 | 0.67 to 2.57 |
Renal failure | 21 (2.42 %) | 2 (1.59 %) | 0.58 | 0.65 | 0.15 to 2.81 |
Pre-syncope/Syncope | 17 (1.96 %) | 3 (2.38 %) | 0.75 | 1.22 | 0.35 to 4.23 |
Musculoskeletal | 39 (4.45 %) | 8 (6.35 %) | 0.36 | 1.44 | 0.66 to 3.16 |
Cellulitis | 19 (2.19 %) | 4 (3.17) | 0.49 | 1.47 | 0.49 to 4.38 |
Pain/Weakness | 23 (2.65 %) | 2 (1.59 %) | 0.48 | 0.59 | 0.14 to 2.54 |
Other diagnoses | 106 (12.21 %) | 12 (9.52 %) | 0.38 | 0.76 | 0.40 to 1.42 |